MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Adam Bellack
Adam BellackGoodwin Procter

Adam Bellack

Partner at Goodwin Procter

Lawyer

Washington, D.C.

Deal Bio

Total Deals7
Valued Deals6
Total Value£ 20.21 B
Avg. Deal Size£ 3.37 B

Market Context

Sort

22 Jan 2018|United States|Biotechnology
Juno Therapeutics
Celgene Corporation

Target: JUNO THERAPEUTICS INC

Bidder: CELGENE CORPORATION

9 Service Providers

4 Target | 5 Bidder

60 Dealmakers

22 Target | 38 Bidder

£ 5.86 B

Value

28 Mar 2018|United States|Pharmaceuticals
Icon Bioscience
Eyepoint Pharmaceuticals

Target: ICON BIOSCIENCE INC

Bidder: EYEPOINT PHARMACEUTICALS INC

1 Service Providers

1 Bidder

23 Dealmakers

23 Bidder

£ 70 M

Value

02 May 2018|United States|Biotechnology
Benevir Biopharm
Janssen Biotech

Target: BENEVIR BIOPHARM INC

Bidder: JANSSEN BIOTECH INC

4 Service Providers

1 Target | 1 Bidder | 2 Vendor

19 Dealmakers

1 Target | 2 Bidder | 16 Vendor

£ 733 M

Value

20 May 2019|United States|Biotechnology
Just Biotherapeutics
EVOTEC

Target: JUST BIOTHERAPEUTICS

Bidder: EVOTEC

3 Service Providers

1 Target | 2 Bidder

22 Dealmakers

1 Target | 21 Bidder

£ 71 M

Value

28 Mar 2018|United States|Pharmaceuticals
Icon Bioscience
PSIVIDA

Target: ICON BIOSCIENCE

Bidder: PSIVIDA

5 Service Providers

2 Target | 3 Bidder

15 Dealmakers

10 Target | 5 Bidder

n/a

Value

24 Jul 2023|Italy|Biotechnology
ERYDEL
Quince Therapeutics

Target: ERYDEL

Bidder: QUINCE THERAPEUTICS

11 Service Providers

5 Target | 6 Bidder

74 Dealmakers

36 Target | 38 Bidder

£ 419 M

Value

05 Feb 2024|United States|Pharmaceuticals
Catalent
Novo Holdings

Target: CATALENT INC

Bidder: NOVO HOLDINGS A/S

17 Service Providers

8 Target | 9 Bidder

126 Dealmakers

25 Target | 101 Bidder

£ 13.06 B

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite